Cervarix® Singapore | Shim Clinic
Cervarix® Singapore: Cervarix® in Singapore is a bivalent HPV human papillomavirus recombinant vaccine. Covering HPV types 16, and 18.
Cervarix® [HPV (Human Papillomavirus) Bivalent (Types 16 and 18) Vaccine, Recombinant]
- 2007 – Singapore HSA approval
- 2009 October 16th – US FDA approves use in females aged 10 to 25 years
- 2011 July 19th – US FDA approves use in females as young as 9 years of age
- 2011 August 3rd – Singapore HSA approves use for the prevention of persistent infection, premalignant cervical lesions and cervical cancer